Zentalis Pharmaceuticals, Inc. (ZNTL)
2.42
-0.10
(-3.97%)
USD |
NASDAQ |
Feb 20, 16:00
2.36
-0.06
(-2.48%)
After-Hours: 20:00
Zentalis Pharmaceuticals EPS Diluted (Quarterly) : -0.37 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| STAAR Surgical Co. | 0.1758 |
| Plus Therapeutics, Inc. | -0.0412 |
| BioStem Technologies, Inc. | 0.0328 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Protokinetix, Inc. | -0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.69M |
| Total Expenses (Quarterly) | 26.69M |
| Enterprise Value | -65.39M |
| Earnings Yield | -86.09% |
| Normalized Earnings Yield | -80.95 |